Faculty Opinions recommendation of Sickle cell vaso-occlusion causes activation of iNKT cells that is decreased by the adenosine A2A receptor agonist regadenoson.

@inproceedings{Risitano2013FacultyOR,
  title={Faculty Opinions recommendation of Sickle cell vaso-occlusion causes activation of iNKT cells that is decreased by the adenosine A2A receptor agonist regadenoson.},
  author={A. Risitano and F. Perna},
  year={2013}
}